Green Square advises Engage on its acquisition by Fingerpaint

20th December 2021

We are delighted to have advised Engage In-Health on their acquisition by Fingerpaint Marketing Inc.

Based in London, Engage is an award-winning, digital-first omnichannel healthcare marketing agency which delivers customer engagement strategies and content to global pharma brands. Founded in 2016 by data and medical communications specialists Mary McGregor and Dave Chandler, Engage has grown exponentially through the deployment of its proprietary data solutions, iNCITE, iLLUMINATE and iKOL. These platforms allow the selection and mapping of priority customers, content and channels to drive programme deployment and real-time campaign measurement and analysis.

Based in Saratoga Springs, NY, and backed by San Francisco’s Knox Lane private equity, Fingerpaint has 700 staff, revenues in excess of US$150m and is biopharma’s global commercialisation partner for analytics-enabled integrated solutions. The acquisition of Engage represents Fingerpaint’s first foray outside the US and provides a solid footprint in the UK and EU from which to further expand. Being able to leverage Fingerpaint’s clear content and creative expertise will significantly augment Engage’s client offering.

Mary McGregor and Dave Chandler, co-founders and joint managing partners of Engage commented:

“Becoming part of the Fingerpaint family was the perfect choice for Engage, not only in terms of what the combination of our businesses can achieve, but just as importantly from a chemistry and cultural point of view as our teams share a very similar ethos. Integrating into Fingerpaint will allow us to leverage its award-winning creative and digital talent and maximise omnichannel campaigns as we continue to work with global brands at every stage of the commercialisation process.

Green Square’s expertise stands out and they were the best advisers we could have wished for. They curated a very well-chosen list of potential partners, skilfully guided us through the process and gave excellent advice the whole way. Ultimately they negotiated a transaction which worked perfectly for all parties and we couldn’t be happier.”

Tony Walford, Partner, Green Square commented

”Finding Mary, Dave and the team an acquirer which represents such an excellent fit has been a pleasure. Engage’s growth has been stratospheric and we are really pleased to have been able to place their data-led solutions within the heart of a business growing at similar pace and with synergistic offerings. The opportunity for the combined group to provide its clients with holistic offerings on both sides of the Atlantic is very significant and will further accelerate growth.”

This is the third transaction in the biopharma communications space completed by Green Square in 2021 and follows the sale of ONEHealth to Tokyo’s M3 in March and Indigo Medical to Waterland PE backed IMC in April, further cementing Green Square’s clear expertise in the digital and data-led MedComms arena.

Read more



Knox Lane